Cargando…

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Interferons induced early after SARS-CoV-2 infection are crucial for shaping immunity and preventing severe COVID-19. We previously demonstrated that injection of pegylated interferon-lambda accelerated viral clearance in COVID-19 patients (NCT04354259). To determine if the viral decline is mediated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santer, Deanna M., Li, Daniel, Ghosheh, Yanal, Zahoor, Muhammad Atif, Prajapati, Dhanvi, Hansen, Bettina E., Tyrrell, D. Lorne J., Feld, Jordan J., Gehring, Adam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667439/ https://www.ncbi.nlm.nih.gov/pubmed/36385011 http://dx.doi.org/10.1038/s41467-022-34709-4

Ejemplares similares

Efficacy of antiviral therapy and host–virus interactions visualised using serial liver sampling with fine-needle aspirates
por: Kim, Samuel C., et al.
Publicado: (2023)

The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
por: Egli, Adrian, et al.
Publicado: (2014)

Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population
por: Huang, Peng, et al.
Publicado: (2017)

Interferon-λ and interleukin-22 cooperate for the induction of interferon-stimulated genes and control of rotavirus infection
por: Hernández, Pedro P., et al.
Publicado: (2015)

Interferon-λ at the Center of the Storm
por: Hendricks, Matthew R., et al.
Publicado: (2020)

Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1
por: Miknis, Zachary J., et al.
Publicado: (2010)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection
por: Zahoor, Muhammad Atif, et al.
Publicado: (2022)

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
por: Lazear, Helen M., et al.
Publicado: (2015)

Targeted Induction of Interferon-λ in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection
por: Nakagawa, Shin-ichiro, et al.
Publicado: (2013)

Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
por: Santer, Deanna M., et al.
Publicado: (2020)

The Unresolved Role of Interferon-λ in Asthma Bronchiale
por: Sopel, Nina, et al.
Publicado: (2017)

Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese
por: Chen, Ji-Yih, et al.
Publicado: (2018)

Editorial: Interferon-λs: New Regulators of Inflammatory Processes
por: Zanoni, Ivan, et al.
Publicado: (2019)

Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
por: Santer, Deanna M., et al.
Publicado: (2013)

The μ2 and λ1 Proteins of Mammalian Reovirus Modulate Early Events Leading to Induction of the Interferon Signaling Network
por: Després, Guillaume David, et al.
Publicado: (2022)

Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered
por: Keshvari, Maryam, et al.
Publicado: (2014)

Interferon (IFN)-λ is a potential mediator in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2016)

Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship
por: Finotti, Giulia, et al.
Publicado: (2017)

IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes
por: Egli, Adrian, et al.
Publicado: (2018)

The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases
por: Griffiths, Samantha J., et al.
Publicado: (2015)

Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019
por: O’Brien, Thomas R, et al.
Publicado: (2020)

STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α
por: Yamauchi, Shota, et al.
Publicado: (2016)

Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages
por: Orecchioni, Marco, et al.
Publicado: (2019)

Corrigendum: Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages
por: Orecchioni, Marco, et al.
Publicado: (2020)

Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract
por: Andreakos, Evangelos, et al.
Publicado: (2017)

Interferon-λ in the Context of Viral Infections: Production, Response and Therapeutic Implications
por: Hermant, Pascale, et al.
Publicado: (2014)

Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
por: Krammer, Susanne, et al.
Publicado: (2021)

Interferon-λ Attenuates Rabies Virus Infection by Inducing Interferon-Stimulated Genes and Alleviating Neurological Inflammation
por: Li, Yingying, et al.
Publicado: (2020)

Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
por: Zanoni, Ivan, et al.
Publicado: (2017)

Porcine deltacoronavirus (PDCoV) infection antagonizes interferon-λ1 production
por: Liu, Shudan, et al.
Publicado: (2020)

May interferon λ be a novel therapeutic approach against COVID-19?
por: Roohi, Azam, et al.
Publicado: (2021)

Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense
por: Boulant, Steeve, et al.
Publicado: (2022)

Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2
por: Onabajo, Olusegun O., et al.
Publicado: (2020)

Interferon-λ(4) (IFNL4) Transcript Expression in Human Liver Tissue Samples
por: Amanzada, Ahmad, et al.
Publicado: (2013)

ID: 101: Investigating the role of interferon λ4 in hepatitis C virus infection
por: Terczynska-Dyla, Ewa, et al.
Publicado: (2015)

Clean and folded: Production of active, high quality recombinant human interferon-λ1
por: Shaldzhyan, Aram, et al.
Publicado: (2021)

Elevated Plasma Level of Interferon-λ1 in Chronic Spontaneous Urticaria: Upregulated Expression in CD8(+) and Epithelial Cells and Induction of Inflammatory Cell Accumulation
por: Wang, S. F., et al.
Publicado: (2016)

Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus
por: Hemann, Emily A., et al.
Publicado: (2019)

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus
por: Mosa, Alexander I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cp6kgu7c56dqgu4nhjr66da707